Personalis and Collaborators to Highlight Ultrasensitive ctDNA Data and New Therapy Resistance Tracking Capabilities at AACR 2026

Go back to Personalis and Collaborators to Highlight Ultrasensitive ctDNA Data and New Therapy Resistance Tracking Capabilities at AACR 2026
(NASDAQ: PSNL) Delayed: 10.06 -0.11 (1.08%)
Previous Close $10.17    52 Week High
Open $9.88    52 Week Low
Day High $10.56    P/E N/A 
Day Low $9.76    EPS
Volume 1,204,526